Navigation Links
Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
Date:3/19/2012

SAN DIEGO and PHILADELPHIA, March 19, 2012 /PRNewswire/ -- Toby Odenheim, director of IT services at Synteract, Inc., a full-service contract research organization (CRO), is slated to present on Selecting the Optimum EDC Platform to Support your Clinical Program at the Outsourcing in Clinical Trials, East Coast conference, to be held in Philadelphia, March 27-28, 2012. Odenheim will speak at 11 a.m. EDT, Wed., March 28, discussing a variety of drivers to consider when selecting the right EDC (electronic data capture) platform for clinical project needs.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

The conference is geared towards solution-seeking professionals who want focused research-generated content and innovative strategies to manage the increased complexities in today's drug development environment. Odenheim will discuss working with clients to identify the key drivers for consideration when evaluating electronic data capture platforms to match program needs, such as:

  • Developing a checklist and risk-benefit evaluation to assist in decision-making
  • Assessing different platforms during a clinical program to enhance productivity, cost efficiency and expedite decision points
  • Scrutinizing EDC systems for biotech and pharma development needs

Odenheim has been with Synteract for seven years. He has a master's in business administration and a bachelor's degree in biology, as well as a professional Oracle Database Administration certificate from the University of California San Diego.

According to Stewart Bieler, chief operating officer, Odenheim was chosen to present on behalf of Synteract due to his clear understanding of how critical the application of appropriate technologies is in driving efficiencies and productivity in drug development.

"This is a complex industry that is changing all the time, and clients want to be assured their project will be in the right hands, with a company that has experience helping clients choose the right tools and technology for their drug development needs. Toby has assessed and helped to deliver solutions to clients that best fit their unique program requirements, driving projects and results forward at the same time."

Synteract will exhibit in booth #35; Synteract CEO, Wendel Barr, will also be on hand at the event. Synteract will answer questions about the multiple software and technology platforms it supports within the framework of its full-service CRO capabilities and will discuss how its more than 17 years of experience across a wide range of therapeutic areas can fit specific project needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or at msacher@synteract.com 

About Synteract (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424

 


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. InspireMD Appoints Dr. James Barry to Its Board of Directors
3. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
4. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
5. Berkeley Lab Director Paul Alivisatos wins Wolf Prize in Chemistry
6. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
7. Robert Farrell Joins Bionovos Board of Directors
8. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
9. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. BioStorage Technologies Appoints New Member to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):